Sign in

CIK 0001819411 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Gain Therapeutics, Inc.

Sign in to watch
Ticker
GANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851726310
Phone
(301) 500-1556
Business address
4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
  1. 8-K Event Results of operations
  2. ARS Other Annual Report to Security Holders
  3. DEFA14A Proxy Proxy Materials
  4. DEF 14A Proxy Proxy Statement
  5. 4 Insider Changes in Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 8-K Event Executive or director change · Regulation FD disclosure
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 8-K Event Executive or director change
  15. 8-K Event Regulation FD disclosure
  16. 424B3 Offering Prospectus
  17. EFFECT Other Notice of Effectiveness
  18. 4 Insider Changes in Ownership
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. UPLOAD Other SEC-generated Letter

Page 6 of 13 · 242 filings